1. Home
  2. EVC vs BCYC Comparison

EVC vs BCYC Comparison

Compare EVC & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entravision Communications Corporation

EVC

Entravision Communications Corporation

HOLD

Current Price

$8.76

Market Cap

335.0M

Sector

Industrials

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$4.16

Market Cap

310.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVC
BCYC
Founded
1996
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
335.0M
310.7M
IPO Year
2000
2019

Fundamental Metrics

Financial Performance
Metric
EVC
BCYC
Price
$8.76
$4.16
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$13.90
AVG Volume (30 Days)
3.6M
268.1K
Earning Date
05-05-2026
04-30-2026
Dividend Yield
5.35%
N/A
EPS Growth
47.59
N/A
EPS
0.13
N/A
Revenue
$536,034,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$69.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.95
$4.20
52 Week High
$10.12
$9.36

Technical Indicators

Market Signals
Indicator
EVC
BCYC
Relative Strength Index (RSI) 58.58 33.87
Support Level $2.70 N/A
Resistance Level $10.12 $4.75
Average True Range (ATR) 0.73 0.18
MACD -0.19 -0.03
Stochastic Oscillator 47.55 11.94

Price Performance

Historical Comparison
EVC
BCYC

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the advertising and technology services segment. Geographically, the company generates the majority of its revenue from the United States.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.

Share on Social Networks: